Senseonics Holdings, Inc. Files 8-K on Jan 8 Events

TL;DR

SENS filed an 8-K on Jan 13 detailing Jan 8 events - check financials.

AI Summary

Senseonics Holdings, Inc. filed an 8-K on January 13, 2025, reporting on events that occurred on January 8, 2025. The filing pertains to results of operations, financial condition, and other events, including financial statements and exhibits. The company is incorporated in Delaware and headquartered in Germantown, MD.

Why It Matters

This 8-K filing provides an update on Senseonics Holdings' financial condition and operational results, which could impact investor understanding of the company's performance.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting on operational and financial events, not indicating any immediate or significant new risks.

Key Players & Entities

• Senseonics Holdings, Inc. (company) — Registrant
• January 8, 2025 (date) — Earliest event reported
• January 13, 2025 (date) — Filing date
• Germantown, MD (location) — Principal Executive Office

FAQ

Key Financial Figures

• $8.3 million — nary unaudited revenue of approximately $8.3 million for the fourth quarter of 2024, and pre
• $22.5 million — nary unaudited revenue of approximately $22.5 million for the year ended December 31, 2024
• $74.9 million — , 2024, is expected to be approximately $74.9 million The Company also reported the followi

Filing Documents

• tm252718d1_8k.htm (8-K) — 33KB
• tm252718d1_ex99-1.htm (EX-99.1) — 24KB
• tm252718d1_ex99-1img001.jpg (GRAPHIC) — 4KB
• 0001104659-25-002855.txt ( ) — 240KB
• sens-20250108.xsd (EX-101.SCH) — 3KB
• sens-20250108_lab.xml (EX-101.LAB) — 33KB
• sens-20250108_pre.xml (EX-101.PRE) — 22KB
• tm252718d1_8k_htm.xml (XML) — 3KB

02 Results of Operations and

Item 2.02 Results of Operations and Financial Condition. On January 8, 2025, Senseonics Holdings, Inc. (the "Company") issued a press release announcing, among other things, business updates, including certain preliminary, unaudited financial information for the year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. The information set forth in this Item 2.02 and contained in the press release furnished as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is not incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing.

01 Other Events

Item 8.01 Other Events. On January 8, 2025, the Company announced its decision to cancel the Special Meeting of Stockholders, which had been scheduled for January 10, 2025, for the purpose of seeking stockholder approval of a proposed reverse stock split within the range of 25:1 to 50:1. On January 8, 2025, the Company also reported the following preliminary unaudited financial information: The Company generated preliminary unaudited revenue of approximately $8.3 million for the fourth quarter of 2024, and preliminary unaudited revenue of approximately $22.5 million for the year ended December 31, 2024 Total unaudited operating expenses and associated cash utilization for the fourth quarter of 2024 and full year 2024 were consistent with the Company's previously provided guidance The Company's unaudited balance of cash, cash equivalents and restricted cash as of December 31, 2024, is expected to be approximately $74.9 million The Company also reported the following operational information: The Company's patient base increased 56% in 2024 over 2023 to approximately 6,000 global patients

Forward Looking Statements

Forward Looking Statements Any statements in this report about future expectations, plans and prospects for the Company, including the anticipated level of fourth quarter 2024 and full year 2024 revenue and cash, cash equivalents and restricted cash as of December 31, 2024 constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: uncertainties inherent in the financial close process in connection with the finalization of the Company's 2024 financial statements, as well as the audit of such financial statements by the Company's independent registered public accounting firm and such other factors as are set forth in the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, and subsequent reports filed with the Securities and Exchange Commission under the heading "Risk Factors." The forward-looking events and developments will cause the Company's views to change. However, while the Company may elect to update these forward-looking forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof. Preliminary Unaudited Financial Information The preliminary financial information presented in this report are estimates based on information available to management as of the date of this report, have not been reviewed or audited by the Company's independent registered public accounting firm and are subject to change.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release dated January 8, 2025, titled "Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting." 104 Cover Page Interactive Data (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 SENSEONICS HOLDINGS, INC. By: /s/ Rick Sullivan Name: Rick Sullivan Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR